In today’s episode we have updates which include approval of Skytrofa, a new human growth hormone, and approval of Invega Hafyera, a twice yearly treatment for schizophrenia. We'll also be going over a new warning issued by the FDA on JAK inhibitors. Don't forget to like, share and subscribe, and ENJOY!